Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.9 (
glucose-6-phosphatase
)
3,081
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have previously reported that the CDX1 homeoprotein interacts with the TATA-box binding protein (TBP) on the promoter of the
glucose-6-phosphatase
(
G6Pase
) gene. We show here that CDX1 interacts with TBP via the homeodomain and that the transcriptional activity additionally requires the N-terminal domain upstream of the homeodomain. CDX1 interacting with TBP is connected to members of the TFIID and Mediator complexes, two major elements of the general transcriptional machinery. Transcription luciferase assays performed using an altered-specificity mutant of TBP provide evidence for the functionality of the interaction between CDX1 and TBP. Unlike CDX1,
CDX2
does not interact with TBP nor does it transactivate the
G6Pase
promoter. Swapping experiments between the domains of CDX1 and
CDX2
indicate that, despite opposite functional effects of the homeoproteins on the
G6Pase
promoter, the N-terminal domains and homeodomains of both CDX1 and
CDX2
have the intrinsic ability to activate transcription and to interact with TBP. However, the carboxy domains define the specificity of CDX1 and
CDX2
. Thus, intra-molecular interactions control the activity and partner recruitment of CDX1 and
CDX2
, leading to different molecular functions.
...
PMID:Functional interaction between the homeoprotein CDX1 and the transcriptional machinery containing the TATA-binding protein. 1715 64